IP Library Granted Patent US 11,357,233
Granted Patent B2
US 11,357,233 · App. 16/623,055 · Granted Jun 14, 2022

Microbial consortium for suppressing non-GRAS microorganisms on a surface

Inventors: Willy Verstraete (Wondelgem, BE); Vanda Isabel Machado Branco (Wondelgem, BE); Mariane Adèle Leona Wambeke (Wondelgem, BE)
Assignee: AVECOM NV
A01N63/20A01N63/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,357,233
App. No.
16/623,055
Granted
Jun 14, 2022
Kind
B2
Abstract

The current invention provides for a microbial consortium comprising one or more ammonium-oxidizing strains which are generally recognized as safe (GRAS) and which are selected from the group of Nitrosomonas, Nitrosospira, Nitrosopumilus, Cenarchaeum, Nitrosoarchaeum, Nitrosocaldus, Caldiarchaeum ; and one or more GRAS strains which are commensal to the one or more ammonium-oxidizing strains, and which are selected from the group of Acinetobacter, Alcaligenes, Arthrobacter, Azospirillum, Azotobacter, Bacillus, Beijerinckia, Enterobacter, Erwinia, Flavobacterium, Rhizobium, Serratia and Deinococcus.

Claims (14)

1. A microbial consortium which comprises:

one or more ammonium-oxidizing strains which are generally recognized as safe (GRAS), selected from the group of Nitrosomonas, Nitrosospira, Nitrosopumilus, Cenarchaeum, Nitrosoarchaeum, Nitrosocaldus , and Caldiarchaeum ; and

one or more GRAS strains which are commensal to the one or more ammonium-oxidizing strains, and which are selected from the group of Acinetobacter, Alcaligenes, Arthrobacter, Azospirillum, Azotobacter, Bacillus, Beijerinckia, Enterobacter, Erwinia, Flavobacterium, Rhizobium, Serratia and Deinococcus,

wherein the microbial consortium comprises cells of the one or more ammonium-oxidizing strains in a ratio of between 100:10 and 100:0.1 as compared to cells of the one or more commensal strains.

2. Microbial consortium according to claim 1 , characterized in that said consortium comprises at least two ammonium-oxidizing strains, and at least three commensal strains.

3. Microbial consortium according to claim 2 , characterized in that the microbial consortium comprises an excess of the one or more ammonium-oxidizing strains as compared to the one or more commensal strains.

4. Microbial consortium according to claim 1 , characterized in that the microbial consortium comprises biomass of the one or more ammonium-oxidizing strains in a ratio between 100:10 and 100:0.1 as compared to biomass of the one or more commensal strains.

5. Microbial consortium according to claim 1 , characterized in that the microbial consortium comprises one or more ammonium-oxidizing strains selected from the group of Nitrosomonas marina, Nitrosomonas nitrosa, Nitrosomonas eutropha, Nitrosomonas europaea, Nitrosomonas cryotolerans, Nitrosospira multiformis, Nitrosospira lacus, Nitrosopumilus maritimus, Cenarchaeum symbiosum, Nitrosoarchaeum limnia, Nitrosocaldus yellowstonii , and Caldiarchaeum subterraneum.

6. Microbial consortium according to claim 1 , characterized in that the microbial consortium comprises one or more commensal strains selected from the group of Bacillus subtilis, Bacillus megaterium, Bacillus polymyxa, Bacillus amyloliquefaciens, Bacillus cereus, Bacillus japonicum or from the group of Deinococcus.

7. Microbial consortium according to claim 1 , characterized in that the microbial consortium shows an enhanced resilience as compared to a separate population of the one or more ammonium-oxidizing strains present in said microbial consortium and to a separate population of the one or more commensal strains present in said microbial consortium.

8. Microbial consortium according to claim 1 , characterized in that the nitrifying activity of the microbial consortium is at least 0.16 g nitrogen/g volatile suspended solids (VSS) per day.

9. Microbial consortium according to claim 1 , characterized in that the oxygen uptake rate of the microbial consortium is at least 8 mg O2/g VSS per hour.

10. A formulation comprising the microbial consortium of claim 1 in the form of an aqueous composition or an aqueous suspension.

11. A formulation comprising the microbial consortium according to claim 1 , and further comprising one or more of a surfactant, emulsifier, fatty acid, odor-controlling agent, thickener, chelating agent, crystal growth inhibitor, polymer, solvent, or perfume.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2020
From: VERSTRAETE, WILLY; BRANCO, VANDA ISABEL MACHADO; WAMBEKE, MARIANE ADÈLE LEONA
To: AVECOM NV
Reel/Frame 052257/0798 →
Priority Claims (1)
BE 2017/5431 · Jun 16, 2017 · national
Continuity (1)
Related Publication 20200163343A1 · May 28, 2020
Cited By (2)
US 12,365,868 US 12,365,869